首站-论文投稿智能助手
典型文献
pPeOp inhibits HGC-27 cell proliferation,migration and invasion by upregulating miR-30b-5p and down-regulating the Rac1/Cdc42 pathway
文献摘要:
Gastric cancer is the fifth most frequently occurring and the fourth most lethal malignant cancer worldwide.A bioactive protein(pPeOp)from Omphalia lapidescens exhibits significant inhibitory effects on gastric cancer cells.miRNA deep sequencing analysis shows that miR-30b-5p is significantly upregulated in HGC-27 cells treated with pPeOp.Verification results show that the expression level of miR-30b-5p is significantly increased in HGC-27 cells after pPeOp treatment.Additionally,miR-30b-5p is significantly downregulated in clinical gastric cancer tissues compared to that in adjacent normal tissues.Following pPeOp treatment and/or transfection with miR-30b-5p mimic,the proliferation,migration,and invasion of HGC-27 cells are significantly impaired.Immunofluorescence microscopy shows that pPeOp and/or miR-30b-5p destroy(s)microfilaments and microstructures and inhibit(s)the formation of pseudopodia.Bioinformatics analysis,dual-luciferase reporter assay,and western blot analysis con-firm that miR-30b-5p downregulates Rac1/Cdc42 expression and activation by targeting RAB22A.Available data indicate that miR-30b-5p plays an anti-gastric cancer role in mediating pPeOp.pPeOp upregulates miR-30b-5p expression,which in turn inhibits RAB22A expression,resulting in a reduction in the expression and activation of Rac1 and Cdc42 and their downstream targets,thus destroying the cytoskeletal structure and inhibiting the pro-liferation,migration,and invasion of cancer cells.
文献关键词:
作者姓名:
Wenjun Xu;Zhenjie Fu;Yuqin Xu;Man Hei Cheung;Yan Chen;Meiai Lin;Hang Wen;Hang Lv;Chun Liang;Jianshu Lou;Yitao Chen
作者机构:
School of Life Science,Zhejiang Chinese Medical University,Hangzhou 310053,China;Division of Life Science,Center for Cancer Research and State Key Lab for Molecular Neural Science,The Hong Kong University of Science and Technology,Hong Kong,China;Department of Gastrointestinal Surgery,the First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310003,China;EnKang Pharmaceuticals(Guangzhou)Ltd.,Guangzhou 510145,China;School of Pharmacy,Hangzhou Normal University,Hangzhou 311121,China
引用格式:
[1]Wenjun Xu;Zhenjie Fu;Yuqin Xu;Man Hei Cheung;Yan Chen;Meiai Lin;Hang Wen;Hang Lv;Chun Liang;Jianshu Lou;Yitao Chen-.pPeOp inhibits HGC-27 cell proliferation,migration and invasion by upregulating miR-30b-5p and down-regulating the Rac1/Cdc42 pathway)[J].生物化学与生物物理学报(英文版),2022(12):1897-1908
A类:
pPeOp,Omphalia,lapidescens,microfilaments,pseudopodia,RAB22A
B类:
inhibits,HGC,proliferation,migration,invasion,by,upregulating,30b,5p,Rac1,Cdc42,pathway,Gastric,cancer,fifth,most,frequently,occurring,fourth,lethal,malignant,worldwide,bioactive,protein,from,exhibits,inhibitory,effects,gastric,cells,miRNA,deep,sequencing,analysis,shows,that,significantly,upregulated,treated,Verification,results,expression,level,increased,after,treatment,Additionally,downregulated,clinical,tissues,compared,adjacent,normal,Following,transfection,mimic,impaired,Immunofluorescence,microscopy,microstructures,formation,Bioinformatics,dual,luciferase,reporter,assay,western,blot,con,firm,downregulates,activation,targeting,Available,data,indicate,plays,anti,role,mediating,upregulates,which,turn,resulting,reduction,their,downstream,targets,thus,destroying,cytoskeletal,inhibiting
AB值:
0.428293
相似文献
CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells
Xiajing LI;Yiyu ZHANG;Ning WANG;Zhaohu YUAN;Xiaojie CHEN;Qicong CHEN;Hui DENG;Xinxin TONG;Honglin CHEN;Yuyou DUAN;Yarning WEI-School of Medicine,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,Shenzhen Longhua Central Hospital,Shenzhen 518000,China;Laboratory of Stem Cells and Translational Medicine,Institutes for Life Sciences,School of Medicine,South China University of Technology,Guangzhou 510000,China;School of Biomedical Sciences and Engineering,Guangzhou International Campus,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,the Second Affiliation Hospital of South China University of Technology,Guangzhou 510000,China;Guangdong Engineering Research Center of Precise Transfusion,Guangzhou 510000,China
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
Fuzheng Kang'ai decoction(扶正抗癌方)inhibits cell proliferation,migration and invasion by modulating mir-21-5p/human phosphatase and tensin homology deleted on chromosome ten in lung cancer cells
LI Jinhua;LIU Chunping;ZHAO Yueyang;WU Wanyin;SUN Pengtao;LI Longmei;YANG Xiaobing;ZHOU Yushu-Department of Ultrasound,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Ultrasound,Institute of Ultrasound in Musculoskeletal Sports Medicine,Guangdong Second Provincial General Hospital,Guangzhou 510317,China;State Key Laboratory of Dampness Syndrome of Chinese Medicine,Guangdong Provincial Hospital of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Hematology,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Oncology,Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。